scispace - formally typeset
X

Xueli Cai

Researcher at Zhejiang University

Publications -  29
Citations -  454

Xueli Cai is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 113 citations.

Papers
More filters
Journal ArticleDOI

Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.

Xinfeng Liu, +87 more
- 01 Feb 2020 - 
TL;DR: There was no evidence of a difference in favourable outcomes of patients receiving endovascular therapy compared with those receiving standard medical therapy alone, and the trial was terminated early after 131 patients had been randomly assigned because of high crossover rate and poor recruitment.
Journal ArticleDOI

Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.

TL;DR: In this article , the role of endovascular therapy for acute stroke with a large infarction has not been extensively studied in differing populations, and the authors conducted a multicenter, prospective, open-label, randomized trial in China involving patients with acute large-vessel occlusion in the anterior circulation and an Alberta Stroke Program Early Computed Tomography Score of 3 to 5 (range, 0 to 10, with lower values indicating larger infarctions) or an infarct-core volume of 70 to 100 ml.
Journal ArticleDOI

Association of inflammatory markers with cerebral small vessel disease in community-based population

TL;DR: In this paper , the authors investigated the relationship of neutrophil count (NC), neutrophils-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) with cerebral small vessel disease.
Journal ArticleDOI

Association of inflammatory markers with cerebral small vessel disease in community-based population

TL;DR: In this paper , the authors investigated the relationship of neutrophil count (NC), neutrophils-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) with cerebral small vessel disease.